Tennessee Oncology, PLLC — Hermitage, Tennessee

Tennessee Oncology, PLLC is a clinical research site located in Hermitage, Tennessee, United States 37076.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology, PLLC has participated in 17 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, HER2 Positive Breast Cancer, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Telik.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology, PLLC?

Tennessee Oncology, PLLC has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology, PLLC conducted?

Tennessee Oncology, PLLC has 17 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, HER2 Positive Breast Cancer, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.

Is Tennessee Oncology, PLLC accredited by Crixeo Health?

Yes — Tennessee Oncology, PLLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.